Dubinsky P, Vojtek V, Belanova K, Janickova N, Balazova N, Tomkova Z
Life (Basel). 2023; 13(7).
PMID: 37511985
PMC: 10381816.
DOI: 10.3390/life13071610.
Kim W, Kim J, Kim W
Investig Clin Urol. 2022; 63(6):592-601.
PMID: 36347548
PMC: 9643724.
DOI: 10.4111/icu.20220294.
Mahase S, Nagar H
Eur Urol Open Sci. 2021; 22:9-16.
PMID: 34337473
PMC: 8317782.
DOI: 10.1016/j.euros.2020.10.001.
Schuler T, Kipritidis J, Eade T, Hruby G, Kneebone A, Perez M
Adv Radiat Oncol. 2019; 4(1):191-200.
PMID: 30706028
PMC: 6349627.
DOI: 10.1016/j.adro.2018.09.013.
Akthar A, Wong A, Parekh A, Hubert G, Son C, Pelizzari C
Adv Radiat Oncol. 2018; 3(3):339-345.
PMID: 30202803
PMC: 6128032.
DOI: 10.1016/j.adro.2018.04.009.
Postoperative adjuvant and very early salvage radiotherapy after prostatectomy in high-risk prostate cancer patients can improve specific and overall survival.
Casas F, Valduvieco I, Oses G, Izquierdo L, Archila I, Costa M
Clin Transl Oncol. 2018; 21(3):355-362.
PMID: 30128953
DOI: 10.1007/s12094-018-1931-3.
Superior metastasis-free survival for patients with high-risk prostate cancer treated with definitive radiation therapy compared to radical prostatectomy: A propensity score-matched analysis.
Markovina S, Meeks M, Badiyan S, Vetter J, Gay H, Paradis A
Adv Radiat Oncol. 2018; 3(2):190-196.
PMID: 29904744
PMC: 6000029.
DOI: 10.1016/j.adro.2017.12.001.
Androgen deprivation therapy during and after post-prostatectomy radiotherapy in patients with prostate cancer: a case control study.
Kim M, Song C, Jeong I, Choi S, Park M, Shim M
BMC Cancer. 2018; 18(1):271.
PMID: 29523103
PMC: 5845289.
DOI: 10.1186/s12885-018-4189-9.
Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological Features.
Hwang W, Tendulkar R, Niemierko A, Agrawal S, Stephans K, Spratt D
JAMA Oncol. 2018; 4(5):e175230.
PMID: 29372236
PMC: 5885162.
DOI: 10.1001/jamaoncol.2017.5230.
Image-guided, whole-pelvic, intensity-modulated radiotherapy for biochemical recurrence following radical prostatectomy in high-risk prostate cancer patients.
Byun S, Kim Y, Ahn H, Kim C
PLoS One. 2018; 13(1):e0190479.
PMID: 29320570
PMC: 5761863.
DOI: 10.1371/journal.pone.0190479.
Post-prostatectomy radiotherapy adversely affects urinary continence irrespective of radiotherapy regime.
Nyarangi-Dix J, Steimer J, Bruckner T, Jakobi H, Koerber S, Hadaschik B
World J Urol. 2017; 35(12):1841-1847.
PMID: 28861691
DOI: 10.1007/s00345-017-2081-x.
Select men benefit from androgen deprivation therapy delivered with salvage radiation therapy after prostatectomy.
Holliday E, Kuban D, Levy L, Bolukbasi Y, Master P, Choi S
Prostate Cancer Prostatic Dis. 2017; 20(4):389-394.
PMID: 28462945
DOI: 10.1038/pcan.2017.24.
Quality of Life after post-prostatectomy intensity modulated radiation therapy to the prostate bed with or without the use of gold fiducial markers for image guidance or higher total radiotherapy doses.
Abuodeh Y, Naghavi A, Juan T, Ma Z, Wilder R
Int Braz J Urol. 2017; 43(4):628-637.
PMID: 28379660
PMC: 5557437.
DOI: 10.1590/S1677-5538.IBJU.2016.0189.
Genomic Classifier Augments the Role of Pathological Features in Identifying Optimal Candidates for Adjuvant Radiation Therapy in Patients With Prostate Cancer: Development and Internal Validation of a Multivariable Prognostic Model.
Dalela D, Santiago-Jimenez M, Yousefi K, Karnes R, Ross A, Den R
J Clin Oncol. 2017; 35(18):1982-1990.
PMID: 28350520
PMC: 6530898.
DOI: 10.1200/JCO.2016.69.9918.
Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer.
Shipley W, Seiferheld W, Lukka H, Major P, Heney N, Grignon D
N Engl J Med. 2017; 376(5):417-428.
PMID: 28146658
PMC: 5444881.
DOI: 10.1056/NEJMoa1607529.
Efficacy of post-operative radiation in a prostatectomy cohort adjusted for clinical and genomic risk.
Ross A, Den R, Yousefi K, Trock B, Tosoian J, Davicioni E
Prostate Cancer Prostatic Dis. 2016; 19(3):277-82.
PMID: 27136742
PMC: 5411670.
DOI: 10.1038/pcan.2016.15.
Variation in the use of postoperative radiotherapy among high-risk patients following radical prostatectomy.
Morgan T, Hawken S, Ghani K, Miller D, Feng F, Linsell S
Prostate Cancer Prostatic Dis. 2016; 19(2):216-21.
PMID: 26951715
DOI: 10.1038/pcan.2016.9.
Wrong to be Right: Margin Laterality is an Independent Predictor of Biochemical Failure After Radical Prostatectomy.
Kang J, Reiter R, Kummer N, Dekernion J, Steinberg M, King C
Am J Clin Oncol. 2015; 41(1):1-5.
PMID: 26237192
PMC: 6946377.
DOI: 10.1097/COC.0000000000000216.
Positive surgical margins after radical prostatectomy: What should we care about?.
Pettenati C, Neuzillet Y, Radulescu C, Herve J, Molinie V, Lebret T
World J Urol. 2015; 33(12):1973-8.
PMID: 25939539
DOI: 10.1007/s00345-015-1580-x.
Postoperative radiotherapy in prostate cancer: Analysis of prognostic factors in a series of 282 patients.
Apicella G, Beldi D, Marchioro G, Torrente S, Tunesi S, Magnani C
Rep Pract Oncol Radiother. 2015; 20(2):113-22.
PMID: 25859400
PMC: 4338215.
DOI: 10.1016/j.rpor.2014.10.001.
